Triple (N = 622) | Dual (N = 57) | p value | Mono (N = 45) | p value | |
---|---|---|---|---|---|
CD4/CD8 ratio | |||||
At switch, mean (SD) | 0.76 (0.45) | 0.80 (0.37) | 0.167 | 0.90 (0.48) | 0.025 |
24 months after switch, mean (SD) | 0.93 (0.71) | 0.88 (0.43) | 0.824 | 1.02 (0.50) | 0.105 |
Change, mean (SD) | +0.17 (0.58) | +0.08 (0.19) | 0.024 | +0.12 (0.22) | 0.786 |
CD8 cell count | |||||
At switch, mean (SD) | 912 (458) | 882 (471) | 0.396 | 812 (363) | 0.173 |
24 months after switch, mean (SD) | 867 (451) | 911 (411) | 0.337 | 913 (575) | 0.870 |
Change, mean (SD) | −45 (401) | +28 (256) | 0.017 | +101 (404) | 0.012 |
CD4 cell count | |||||
At switch, mean (SD) | 588 (285) | 614 (269) | 0.402 | 654 (274) | 0.040 |
24 months after switch, mean (SD) | 683 (294) | 703 (272) | 0.285 | 795 (332) | 0.006 |
Change, mean (SD) | +95 (181) | +89 (175) | 0.943 | +141 (229) | 0.205 |